Delivery Order SPE2DB20D3101-SPE2DB24FREC0

Award Date 3/15/24
Potential Completion Date 4/5/24
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Qulipta 60 mg tablets. The firm-fixed-price delivery order, valued at $1,116.21, has a completion date of December 5, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award, valued at $3,939.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product Qulipta 60 mg Tablet 30s. The award has an ultimate completion date of May 7, 2024 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and the parent company holds a significant...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Qulipta 60 mg tablets. The $1,154.79 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,353.23 delivery order contract is for the supply of Qulipta 30 mg tablets, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of August 21, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,237.40, is for the delivery of the medication Qulipta 60 mg tablets. This is a firm fixed-price delivery order contract, with an ultimate completion date of January 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Qulipta 60 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $7,779.69 Delivery Order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,531.13, is for the delivery of Qulipta 60 MG Tablet 30S, a pharmaceutical product. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,783.24 delivery order contract is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Qulipta 60 mg Tablet 30s. The contract has a ceiling value of $11,265.04 and is for a firm fixed price. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp's Corporate Office Division is the awardee, and the place of performance is Conshohocken, PA. This award is likely...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,116.21 Firm Fixed Price delivery order is for the drug Qulipta 60 mg tablet, with an ultimate completion date of July 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FREC0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,488.28, is for the delivery of a prescription medication, Qulipta 30 mg tablet, with an ultimate completion date of April 5, 2024.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, and holds several other IDCs with government agencies such as the Department of Justice Federal Bureau of Investigation. These contracts enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:43 PM